ASX Announcements

2023


12/12/2023	Final Director's Interest Notice
12/12/2023	RLG Strengthens Board and China Presence
12/12/2023	Initial Director's Interest Notice
30/11/2023	AGM Presentation to Shareholders
30/11/2023	Results of Meeting
23/11/2023	Notification regarding unquoted securities - RLG
23/11/2023	Issue of Performance Rights
13/11/2023	RLG Drives Strong Sales of Minijumbuk Wool Bedding in China
09/11/2023	RLG Expands Co-operation with Shanghai No 1 Pharmacy at CIIE
31/10/2023	Quarterly Activities/Appendix 4C Cash Flow Report
27/10/2023	Notice of Annual General Meeting/Proxy Form
24/10/2023	CCO: Fiji Kava Launches in China on Alibaba's Tmall
06/10/2023	Date of AGM and Closing Date for Director Nominations
03/10/2023	Notice Under Section 708A(5)(e)of the Corporations Act 2001
03/10/2023	Notification regarding unquoted securities - RLG
03/10/2023	Application for quotation of securities - RLG
29/09/2023	Annual Report to shareholders
29/09/2023	Corporate Governance Statement
29/09/2023	Appendix 4G
28/09/2023	Proposed issue of securities - RLG
28/09/2023	RLG Growth Funding
28/09/2023	Proposed issue of securities - RLG
25/09/2023	$1.95 Million Order for Products for Shanghai No. 1 Pharma
18/09/2023	Change of Registry Address Notification
31/08/2023	Preliminary Final Report
30/08/2023	Agreement and 1st Order of $950k for Shanghai No.1 Pharma
22/08/2023	RLG Contracted to Market and Sell Hydralyte in China
22/08/2023	Pause in Trading
16/08/2023	Update - Proposed issue of securities - RLG
16/08/2023	RLG & AuLife Sales Channel Update
08/08/2023	Application for quotation of securities - RLG
07/08/2023	Proposed issue of securities - RLG
31/07/2023	Quarterly Activities/Appendix 4C Cash Flow Report
21/07/2023	Change of Director's Interest Notices - Late Lodgement
14/07/2023	RLG Update
04/07/2023	RLG & AuLife New China Sales Partnership - First Sales
03/07/2023	Change of Director's Interest Notice
03/07/2023	Notification of cessation of securities - RLG
03/07/2023	Resignation of Joint Company Secretary
29/06/2023	Proposed issue of securities - RLG
29/06/2023	RLG Signs Binding Term Sheet for China Sales
08/05/2023	Notice Under Section 708A(5)(e)of the Corporations Act 2001
08/05/2023	Notification of cessation of securities - RLG
08/05/2023	Application for quotation of securities - RLG
08/05/2023	Notification regarding unquoted securities - RLG
28/04/2023	Quarterly Activities/Appendix 4C Cash Flow Report
17/04/2023	Notice Under Section 708A(5)(e)of the Corporations Act 2001
17/04/2023	Application for quotation of securities - RLG
17/04/2023	Notification regarding unquoted securities - RLG
12/04/2023	RLG Appointed to Sell Fiji Kava in China and Australia
12/04/2023	FIJ: Fiji Kava Appoints Roolife as China Distributor
06/04/2023	Change of Director's Interest Notice
14/03/2023	Becoming a substantial holder
13/03/2023	Change of Director's Interest Notice x 2
06/03/2023	RLG Receives Orders To Stock Alibaba's 300 Stores
28/02/2023	H1 FY23 Highlights and Acheivements Presentation
27/02/2023	Appendix 4D and Half Yearly Financial Statements
13/02/2023	Change of Director Interest Notices x 4
10/02/2023	Application for quotation of securities - RLG
10/02/2023	Notice Under Section 708A(5)(e)of the Corporations Act 2001
10/02/2023	Application for quotation of securities - RLG
10/02/2023	Proposed issue of securities - RLG
10/02/2023	RLG Issues Shares on achievement of Milestones
03/02/2023	Revised Securities Trading Policy
31/01/2023	Quarterly Activities/Appendix 4C Cash Flow Report

2022


29/11/2022	AGM Presentation to Shareholders
29/11/2022	Results of Meeting
28/10/2022	Notice of Annual General Meeting/Proxy Form
26/10/2022	Quarterly Activities/Appendix 4C Cash Flow Report
20/10/2022	RLG Launches Its Vora Health Brand
10/10/2022	Date of AGM and Closing Date for Director Nominations
30/09/2022	RLG Enters Into Finance Facility To Drive Sales
30/08/2022	Triple Digit Growth in Platform Sales Underpin FY22 Results
29/08/2022	Appendix 4G
29/08/2022	Corporate Governance Statement
29/08/2022	Preliminary Financial Report and Annual Report
23/08/2022	RLG chosen by Santander UK as China entry provider
28/07/2022	Quarterly Activities/Appendix 4C Cash Flow Report
08/07/2022	RLG & AFT Pharmaceutical OTC medicines launch in China - Upd
07/07/2022	RLG & AFT launch OTC medicines online in China
22/06/2022	Release from Escrow
17/06/2022	Notification of cessation of securities - RLG
28/04/2022	Quarterly Activities/Appendix 4C Cash Flow Report
26/04/2022	RLG Launches TikTok Store in China
08/04/2022	Notification of cessation of securities - RLG
17/03/2022	Notice under Section 708A(5)(e) of the Corporations Act 2001
17/03/2022	Notification regarding unquoted securities - RLG
17/03/2022	Application for quotation of securities - RLG
15/03/2022	Proposed issue of securities - RLG
15/03/2022	Appointment of Corporate Advisory Provider and Appendix 3B
07/03/2022	Appointment of Joint Company Secretary
01/03/2022	RLG selling Aus wool products into China
24/02/2022	Appendix 4D and Half Yearly Report
28/01/2022	Quarterly Activities Report and Appendix 4C

2021


31/12/2021	Notice Under Section 708A(5)(e) of the Corporations Act 2001
31/12/2021	Notification regarding unquoted securities - RLG
31/12/2021	Notification regarding unquoted securities - RLG
31/12/2021	Application for quotation of securities - RLG
30/12/2021	Results of Meeting
20/12/2021	Change of Director's Interest Notice
14/12/2021	Confirmation of Strategic Placement Funds Receipt
02/12/2021	Change of Director Interest Notices x 4
02/12/2021	Notification of cessation of securities - RLG
02/12/2021	Notification regarding unquoted securities - RLG
02/12/2021	Change of Director's Interest Notice
29/11/2021	AGM Presentation to Shareholders
29/11/2021	Results of Meeting
26/11/2021	Notice of General Meeting and Proxy Form
25/11/2021	Completion of Distribution Agreement and Placement Update
15/11/2021	Appointment of new China sales channel and Placement
15/11/2021	Proposed issue of securities - RLG
15/11/2021	Proposed issue of securities - RLG
11/11/2021	Trading Halt
10/11/2021	RooLife Jobkeeper Notice
01/11/2021	Quarterly Activities Report and Appendix 4C
01/11/2021	Change of Director Interest Notice x 3
28/10/2021	Notice of Annual General Meeting/Proxy Form
07/10/2021	Date of AGM and Closing Date for Director Nominations
05/10/2021	Expiry of Listed Options - Letter to Shareholders
27/09/2021	Change of Director's Interest Notice
20/09/2021	Change of Directors Interest Notice x 2
15/09/2021	Change of Director's Interest Notice
10/09/2021	Notice under Section 708A(5)(e) of the Corporations Act 2001
10/09/2021	Notification regarding unquoted securities - RLG
10/09/2021	Application for quotation of securities - RLG
08/09/2021	Proposed issue of securities - RLG
31/08/2021	Appendix 4G
31/08/2021	Corporate Governance Statement
31/08/2021	Appendix 4E, Financial Statements and Annual Report
31/08/2021	Annual Report and Financial Result FY2021
26/08/2021	Change in substantial holding
28/07/2021	Investor Webinar
27/07/2021	Initial Director's Interest Notice
27/07/2021	Final Director's Interest Notice
27/07/2021	RLG Board Changes - Director Appointment and Resignation
21/07/2021	Quarterly Activities and Cashflow Reports
07/07/2021	Becoming a substantial holder
07/07/2021	Notice Under Section 708A(5)(e) of the Corporations Act 2001
07/07/2021	RLG delivers revenue of $3.9m & cashflow positive for Q4FY21
07/07/2021	Application for quotation of securities - RLG
06/07/2021	RLG completes placement to strategic investor raising $1.7m
06/07/2021	Proposed issue of securities - RLG
05/07/2021	Trading Halt
02/07/2021	Change of Director's Interest Notice
02/07/2021	RLG to launch Aus No 1 Kombucha Brand Remedy Drinks in China
01/07/2021	Notification of cessation of securities - RLG
10/05/2021	RLG Management Team Update
30/04/2021	Quarterly Activities Report and Appendix 4C
27/04/2021	Appendix 2A
30/03/2021	RLG Q3 Revenue up 40% on guidance
01/03/2021	Change of Director Interest x 3
23/02/2021	Corporate Presentation
23/02/2021	Appendix 4D and Half Yearly Financial Report
28/01/2021	Quarterly Activity and Cash Flow Report
27/01/2021	RLG and Blis Technologies Flagship Store launches in China
19/01/2021	RLG and Murray River Organics Partner for Global Sales

2020


31/12/2020	Notice Under Section 708A(5)(e) or the Corporations Act 2001
31/12/2020	Appendix 2A
21/12/2020	RLG adds International Produce Supplier in China
27/11/2020	Notice Under Section 708A(5)(e) of the Corporations Act 2001
27/11/2020	Appendix 2A
24/11/2020	Results of Meeting
17/11/2020	RLG on track for Strong Nov Rev and Launches Reid Fruits App
17/11/2020	RLG appointed to sell Cosmetics Brand Kadalys into China
05/11/2020	Corporate Presentation
29/10/2020	Quarterly Activities Report and Appendix 4C
22/10/2020	Kiwi Health Flagship Store Launches in China on Tmall Global
20/10/2020	Response to ASX Price and Volume Query
20/10/2020	Notice of Annual General Meeting/Proxy Form
14/10/2020	Entitlement Issue Shortfall Offer Completed
14/10/2020	Appendix 2A
08/10/2020	Change of Director Interest Notices x 3
08/10/2020	Appendix 2A
06/10/2020	Entitlement Issue and Shortfall Offer Fully Subscribed
28/09/2020	RLG appointed to sell Total Beauty Network's INIKA Organic
23/09/2020	Notice Under Section 708A(5)(e) of the Corporations Act 2001
23/09/2020	Appendix 2A
23/09/2020	Appendix 3Y - Change of Director Interest x 2
21/09/2020	Conversion of Performance Shares
21/09/2020	Entitlement Issue - Extension of Closing Date
28/08/2020	Appendix 4E and Annual Report to Shareholders
28/08/2020	Appendix 4G
28/08/2020	Corporate Governance Statement
28/08/2020	Appendix 4E and Annual Report to Shareholders
27/08/2020	Appendix 2A
26/08/2020	RooLife Rights Issue Timetable Clarification
25/08/2020	Disclosure Document - Rights Issue Prospectus
21/08/2020	Placement and Entitlement Issue to Raise up to $6.2m
21/08/2020	Clarification to Placement Announcement
21/08/2020	Proposed issue of Securities - RLG
21/08/2020	Proposed issue of Securities - RLG
19/08/2020	Trading Halt
17/08/2020	RLG to launch NZX Listed Blis Technologies products in China
05/08/2020	Corporate Presentation
31/07/2020	Quarterly Activity and Cash flow Reports
10/07/2020	RLG and AFT Launch Online New Zealand Health Store in China
08/07/2020	Trading Halt
28/05/2020	SLG Brands appoints RooLife to sell COLAB Shampoo in China
07/05/2020	Media Interview - RooLife Quarterly Overview
30/04/2020	Quarterly Activities Report and Appendix 4C
20/04/2020	RooLife Appointed Alipay Marketing Partner
09/04/2020	RooLife Market Update
06/04/2020	RooLife & AFT Pharmaceuticals - China Update
02/04/2020	Pause in Trading
02/04/2020	Trading Halt
10/03/2020	Notice Under Section 708A(5)(e) of the Corporations Act 2001
10/03/2020	Appendix 3Y x 2
10/03/2020	Appendix 2A
10/03/2020	Appendix 3G
10/03/2020	RLG to sell Nuria Beauty in China for Small World Brands
06/03/2020	Results of Meeting
05/03/2020	Appendix 3B
02/03/2020	Australia and China Digital Marketing and e-Commerce Update
25/02/2020	Appendix 4D and Half Yearly Financial Statements
03/02/2020	Notice of General Meeting/Proxy Form
03/02/2020	Initial Director's Interest Notice
03/02/2020	Final Director's Interest Notice
03/02/2020	RLG Board Changes, Director Resignation and Appointment
31/01/2020	Boardroom Media Interview - December Quarter Review
30/01/2020	Quarterly Activities Report and Appendix 4C

2019


17/12/2019	Appendix 3B
17/12/2019	Notice Under Section 708A(5)(e) of the Corporations Act 2001
11/12/2019	Additional Funds Raised Through Placement
10/12/2019	Placement Completed Successfully Raising $1.5m
09/12/2019	Notice Under Section 708A(5)(e) of the Corporations Act 2001
06/12/2019	Trading Halt
06/12/2019	Forthcoming Release of Voluntary Escrowed Securities
04/12/2019	Appendix 3B
04/12/2019	Partnership with WMall, new China Diagou e-Commerce Platform
04/12/2019	OpenDNA renamed RooLife Group Ltd and QBID Completion
02/12/2019	Results of Meeting
28/11/2019	Acquisition of China e-Commerce Business QBID
31/10/2019	Quarterly Activities and Cash Flow Reports
28/10/2019	Notice of Annual General Meeting/Proxy Form
21/10/2019	TechKnow Invest Conference Presentation
16/10/2019	Notice under Section 708A(5)(e) of the Corporations Act 2001
16/10/2019	Completion of Capital Raising and Appendix 3B
14/10/2019	Response to ASX aware query
14/10/2019	OPN Appointed Digital Partner to drive Brand for NBCF
14/10/2019	Trading Halt
14/10/2019	Pause in Trading
16/09/2019	OPN to Acquire China e-Commerce Business QBID
16/09/2019	OPN Partners with Lobster Shack and Agrees $500k Placement
12/09/2019	Trading Halt
09/09/2019	Change of Director interest Notice x 2
05/09/2019	Appendix 4G
05/09/2019	Corporate Governance Statement
05/09/2019	Full Year Statutory Accounts & Annual Report to Shareholders
29/08/2019	Preliminary Final Report
06/08/2019	OPN & Perth Airport partner to tap into China Tourism Market
30/07/2019	Quarterly Activities Report and Appendix 4C
01/07/2019	Notice under Section 708A(5)(e) of the Corporations Act 2001
01/07/2019	Completion of Tranche 2 Placement and Appendix 3B
28/06/2019	ODA: Calendar Cheese Contract Renewal and China VIE
28/06/2019	OPN Option on VIE Structure
28/06/2019	Results of Meeting
28/06/2019	Investor Update
24/06/2019	OPN's RooLife to sell Petrus Pharmaceuticals into China
29/05/2019	OPN's AI Platform to launch in world's largest online market
27/05/2019	Notice of General Meeting
14/05/2019	Notice Under Section 708A(5)e) of the Corporations Act 2001
14/05/2019	Appendix 3B
03/05/2019	Notice Under Sec 708A(5)(e) of the Corporations Act 2001
01/05/2019	Completion of Share Issue and Appendix 3B
30/04/2019	Quarterly Activities Report and Appendix 4C
23/04/2019	INP: INP Completes the Performance Marketing Transaction
23/04/2019	OpenDNA Completes Digital Marketing Company Acquisition
15/04/2019	Placement Completed Oversubscribed
12/04/2019	OPN to Acquire Digital Marketing Company
12/04/2019	INP: INP Sells Performance Marketing business to OpenDNA
11/04/2019	Trading Halt
11/04/2019	Pause in Trade
08/04/2019	NOV: Expansion of China Payments partnerships and processing
08/04/2019	RooLife platform extends reach with Novatti China Payments
02/04/2019	Initial Director's Interest Notice
02/04/2019	Final Director's Interest Notice
02/04/2019	OPN Board Changes - Director Resignation & Appointment
15/03/2019	EVE: Meluka Honey Appoints OpenDNA (Revised)
14/03/2019	OPN's RooLife to sell Australian Tourism packages to China
12/03/2019	OPN's RooLife to market & sell EVE's Meluka Honey in China
12/03/2019	EVE: Meluka Honey Appoints OpenDNA for Chinese Market Entry
08/03/2019	Response to ASX Appendix 3Y Query
01/03/2019	Change of Director's Interest Notice
27/02/2019	Appendix 4D and Half Yearly Financial Report
27/02/2019	OPN signs deal with Better Nature to sell online into China
25/02/2019	OPN secures Health & Wellbeing supply channel for China
06/02/2019	Top 20 Option Holders and Distribution Schedule
01/02/2019	Appendix 3B
31/01/2019	Quarterly Report and Appendix 4C
30/01/2019	Disclosure Document - Cleansing Prospectus
21/01/2019	Change of Director's Interest Notice
21/01/2019	Appendix 3B

2018


27/12/2018	Notice Under Sec 708A(5)(e) of the Corporations Act 2001
24/12/2018	Change of Director's Interest Notice
24/12/2018	Initial Director's Interest Notice
24/12/2018	Appendix 3B
21/12/2018	Completion of Acquisition and Board and Management Changes
17/12/2018	Notice Under Sec 708A(5)(e) of the Corporations Act 2001
12/12/2018	Completion of Tranche 2 Placement and Appendix 3B
12/12/2018	Change of Director's Interest Notice x2
26/11/2018	Investor Presentation
23/11/2018	Results of Meeting
19/11/2018	Appendix 3B
02/11/2018	Forthcoming Release of Restricted Securities
31/10/2018	Appendix 4C - quarterly
23/10/2018	Notice of Annual General Meeting
01/10/2018	Notice under Section 708A(5)(e) of the Corporations Act 2001
28/09/2018	Completion of Tranche 1 of Placement and Appendix 3B
20/09/2018	Full Year Stat Accounts and Annual Report to Shareholders
20/09/2018	Corporate Governance Statement
20/09/2018	Appendix 4G
12/09/2018	ODA: Divestiture and China Mobile Debt Updates
12/09/2018	OPN Signs Binding Acquisition Agreement and $2.5m Placement
10/09/2018	Trading Halt
29/08/2018	Preliminary Final Report
31/07/2018	Appendix 4C and Quarterly Update
05/06/2018	Corporate Governance Statement
30/04/2018	Quarterly Update 4C
30/04/2018	Appendix 4C - quarterly
26/04/2018	User Privacy & GDPR Solution for Businesses & Consumers
05/04/2018	The Drinks Library App now available in the Apple iOS Store
28/03/2018	Endeavour Drinks Group Launches OPN AI Drinks Library APP
28/02/2018	Appendix 4D and Half Yearly Report and Accounts
31/01/2018	FMT launches smart phones with OPN's Jottr AI News App
25/01/2018	Activity Report and Appendix 4C

2017


30/11/2017	Results of Meeting
30/11/2017	Final Director's Interest Notice
30/11/2017	AGM Presentation to Shareholders
22/11/2017	OpenDNA to Power Boardroom.Media
17/11/2017	TMT Analytics Research Report
01/11/2017	Appendix 4C - quarterly and Update
27/10/2017	Notice of Annual General Meeting
05/10/2017	OPN signs Master Services Agreement with Expert System
03/10/2017	MOU with innovative gaming community creator Uproar
29/09/2017	Appendix 4G
29/09/2017	Full Year Statutory Accounts & Annual Report to Shareholders
28/09/2017	OPN signs MOU with International Publisher Epoch Times
26/09/2017	MOU with leading virtual world company Gaia Interactive
18/09/2017	Operational Update
13/09/2017	OPN Launches Business-Ready Data Visualization Tools
08/09/2017	Appendix 3B
04/09/2017	Investor Presentation
31/08/2017	Appendix 4E - Preliminary Final Report
23/08/2017	Forthcoming Release of Restricted Securities
17/08/2017	TMT Analytics Research Report
10/08/2017	Binding MOU With Leading BI Platform Provider Looker
28/07/2017	Appendix 4C and Quarterly Update
25/07/2017	IRIS tool to significantly enhance OpenDNA AI System
17/07/2017	OpenDNA to create APP for Endeavour Drinks Group
13/07/2017	Trading Halt
12/07/2017	Luxury Publisher Launches New AI App Featuring OPN Tech
04/07/2017	OpenDNA Releases Enhanced Jottr Smart App
27/06/2017	OpenDNA Pioneers AI Expansion Into Mobile Hardware
27/04/2017	Quarterly Activities and Cashflow Report
31/03/2017	Company Secretary Appointment/Resignation
31/03/2017	Details of Company Address
22/03/2017	OpenDNA Signs Ad Tech Agreements with Facebook and Fyber
20/03/2017	OpenDNA to Present at TechKnow Invest Roadshows
09/03/2017	Investor Update - March 2017
23/02/2017	Appendix 4D and Half Year Accounts
09/02/2017	OPN Launches SportsBlog Apps
31/01/2017	Quarterly Activities Report and Appendix 4C
24/01/2017	OPN Signs Major UK Travel Brand
18/01/2017	Appendix 3B - Issue of Options

2016


23/12/2016	MoU signed with MediaFuse
07/12/2016	Q&A Session with CEO Jay Shah
18/11/2016	OpenDNA Strengthens International Sales Team
16/11/2016	Personalisation Technology Company OpenDNA Lists on the ASX
15/11/2016	Updated statement of commitments
15/11/2016	Admission to the Official List
15/11/2016	ASX Circular - Admission and Commencement of Quotation
15/11/2016	Pre-Quotation Disclosure
15/11/2016	Distribution Schedule
15/11/2016	Top 20 Holders
15/11/2016	Appendix 1A and Information Form and Checklist
15/11/2016	Constitution
15/11/2016	Updated pro-forma statement of financial position
15/11/2016	Terms of employee share option plan
15/11/2016	Securities trading policy
15/11/2016	Capital structure and restricted securities schedule
15/11/2016	Full terms of Performance Shares
15/11/2016	Initial Substantial Holder Notices
15/11/2016	Initial Director's Interest Notices
07/10/2016	Prospectus

Are you ready to unlock a world of potential?

'New Market Ready' Consultation
Ready to expand into new markets and want to understand the potential for your business? Contact us to organise a ‘New Market Ready’ consultation. Pre-qualify using RLG's ‘New Market Ready’ survey to be completed prior.